Based on the observed metabolic improvements of Ad-Trim21–injected mice, and due to the association between fructose consumption and NASH progression, we decided to further elucidate the function of hepatic TRIM21 in the pathogenesis of NASH. The gene discussed is TRIM21; the disease is metabolic dysfunction-associated steatohepatitis.